Categories Earnings, Health Care
Earnings Summary: Highlights of Centene Corp’s Q4 2023 financial results
Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced fourth-quarter 2023 results, reporting an increase in revenues and a fall in adjusted earnings.
- Fourth-quarter revenue increased to $39.46 billion from $35.56 billion in the prior year quarter
- Premium and Service revenues moved up 5% to $35.3 billion in Q4 from $33.6 billion in the comparable period of 2022
- Net income was $45 million or $0.08 per share in Q4, compared to a loss of $213 million or $0.38 per share last year
- Adjusted earnings declined to $0.45 per share in the fourth quarter from $0.86 per share in the same period last year
- The health benefits ratio was 89.5%, representing an increase from 88.7% in the year-ago period
- The company generated cash flow from operations of $217 million for the December quarter
- As of December 31, 2023, Centene had cash, investments, and restricted deposits of $37.3 billion
- During the quarter, the Company repurchased 397 thousand shares for $27 million
- The management raised its 2024 Premium & Service revenue guidance by $2.5 billion to $134.5-$137.5 billion
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was